PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 8711560

Tuberculosis Control Programme Practical Guidelines, 1996--treatment regimens.

R J Peto·T J Matthews
View original source ↗Export metadata ↓

Abstract

The source did not provide an abstract. Follow the original record for more information.

Explore related subjects

Antitubercular AgentsEthambutolHumansPractice Guidelines as TopicPyrazinamideTuberculosisLetter

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

R J Peto, T J Matthews. 1996. Tuberculosis Control Programme Practical Guidelines, 1996--treatment regimens.. https://pubmed.ncbi.nlm.nih.gov/8711560/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1999

Confluent hepatic fibrosis in monozygotic twins.

The MRI and CT features of confluent hepatic fibrosis (CHF) are reported in two 6-year-old twins. This is the first case report in children of this little known entity, which may mimic mass lesions, and the first to describe an association of CHF with anti-tuberculous drugs.

Antitubercular Agents↗
PubMed1999

Development of rifapentine susceptibility tests for Mycobacterium tuberculosis.

Two methods for testing the susceptibility of Mycobacterium tuberculosis to rifapentine have been developed: the agar proportion method and the radiometric BACTEC technique. A critical concentration of 0.5 microg of rifapentine per ml is proposed for both methods since it provides a reliable means of distinguishing between susceptible and resistant M. tuberculosis isolates. It is recommended that two quality control M. tuberculosis strains be used at the introduction of these tests in a clinical laboratory: one that is pansusceptible (H37Rv) and one that is resistant to rifapentine. The resistant strain can be obtained from the American Type Culture Collection, where it is deposited under the number ATCC 700457.

Antitubercular Agents↗